Clinical Trial Update: The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy of the oral Rotavirus vaccine ROTAVAC 5D (116E) in Chilean infants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• ROTAVAC 5D (Rotavirus vaccine, live attenuated)

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Rotavirus Infection of Children | Phase 3 | Status: ACTIVE_NOT_RECRUITING